COOBERPHARM SL
Company details
- Active NIF/CIF: B64961691
-
-
-
-
Address: CL BRUSI 7 LOCAL (BARCELONA)
-
-
Featured products:
More information on COOBERPHARM SL
-
19/07/2012 | BORME act no.: 304292 | Register: BARCELONARevocaciones
-
19/07/2012 | BORME act no.: 304292 | Register: BARCELONANombramientos
-
30/09/2011 | BORME act no.: 666198 | Register: BARCELONADepósito de cuentas anuales (Agosto de 2011)
-
21/09/2010 | BORME act no.: 600615 | Register: BARCELONADepósito de cuentas anuales (Agosto de 2010)
-
24/11/2009 | BORME act no.: 928655 | Register: BARCELONADepósito de cuentas anuales (Octubre de 2009)
-
26/12/2008 | BORME act no.: 596203 | Register: BARCELONAConstitución
-
26/12/2008 | BORME act no.: 596203 | Register: BARCELONANombramientos
-
26/12/2008 | BORME act no.: 596203 | Register: BARCELONAOtros conceptos
Other information
The CIF assigned to COOBERPHARM SL is B64961691, and its business status is active. The company is engaged in an economic activity classified within the CNAE 4646 - Comercio al por mayor de productos farmacéuticos. In addition, its SIC identification - also defines it.
COOBERPHARM SL employs a team of Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona, and has 2 executive positions. Its most recent announcement in the Borme was published on 19/07/2012, while its last deposit of ordinary annual accounts is for the - fiscal year.
To access the contact information of COOBERPHARM SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about COOBERPHARM SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about COOBERPHARM SL is extracted from official sources and is updated daily.
Do you want to know more about COOBERPHARM SL??
Find out more about this company by consulting these reports: